Perspectives

Perspectives

Commentary and highlights from contributors and readers

You Make the Call

The significance of JAK2-positive test results in a healthy patient

Here’s how readers responded to a You Make the Call question about the significance of JAK2-positive test results in a healthy patient. Disclaimer: ASH does...
You Make the Call

Reader Responses: The significance of JAK2-positive test results in a healthy patient

Here’s how readers responded to a You Make the Call question about the significance of JAK2-positive test results in a healthy patient. Disclaimer: ASH does not...

An Ode to Joy

We have new leadership at my institution, who, in an act of inspiration (or accidental greatness), have declared that bringing joy back to the...

An ASH Annual Meeting Post-Vivum

“So, what did you learn from ASH?” asked my advisor a couple of weeks after I returned from my first American Society of Hematology...

Cinder, a New Dating App From ASH!*

In preparation for Valentine’s Day, ASH Clinical News has been trolling for ways to promote that most elusive of emotions – love – while...
You Make the Call

Best options for an older patient with Ph+ B-cell ALL

Here’s how readers responded to a You Make the Call question about best options for an older patient with Philadelphia chromosome (Ph)–positive B-cell acute...
Alice Ma, MD

Rituals of the Season

I’ll never forget my first American Society of Hematology (ASH) annual meeting. I was a second-year fellow and a novice at “ASHing.” My mentors had...
You Make the Call

How to treat a young woman with stage 2a Hodgkin lymphoma and fertility concerns?

Here’s how readers responded to a You Make the Call question about treatment options for a young woman with stage 2a Hodgkin lymphoma and...

Biosimilars in Hematology: A Work in Progress

Recently, I was reviewing editorial content for ASH Clinical News, when I came across an article covering the U.S. Food and Drug Administration’s (FDA’s)...

#SHEmatology and #WOMANcology: Encouraging Women to Explore Careers and Leadership in Hematology and Oncology

Over the past 50 years, women in medicine have gained greater representation, with each generation of trainees moving closer to gender parity. The number...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.